Wire Stories

Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer

TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced…

MOGU Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results

Live Video Broadcast Business (“LVB”) Maintains Robust Growth Momentum with GMV in the Fourth Quarter…

Indian OTT and Pay TV Market Analysis and Trajectory 2018-2025 – Netflix, Amazon Prime Video, Disney+, Apple TV+, Zee5 and More – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "India OTT and Pay TV Forecasts" report has been added to ResearchAndMarkets.com's offering.…

Renesas Electronics Announces Consolidated Forecasts for the Second Quarter and First Half of 2020

TOKYO--(BUSINESS WIRE)--Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced…

Wipro Appoints Thierry Delaporte as CEO & Managing Director

EAST BRUNSWICK, N.J. & BANGALORE, India--(BUSINESS WIRE)--#RishadPremji--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a…

Wipro Limited Appoints Deepak M Satwalekar to its Board

BANGALORE, India & EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--#DeepakSatwalekar--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a…

Reveal Group is First and Only Partner to Achieve Blue Prism “Double Platinum” Capability Certification

Company Sets New Standard for Intelligent Automation Delivery Capabilities NEW YORK & SYDNEY--(BUSINESS WIRE)--#BluePrism--Reveal Group,…

New data show first-line triplet regimen of pembrolizumab, Herzuma® (biosimilar trastuzumab) and chemotherapy are effective in treatment of HER2-positive advanced gastric cancer

Data from a phase Ib/II trial show a first-line triple combination therapy of pembrolizumab, Herzuma®(biosimilar…

European Commission Releases Takeda From Commitment to Divest Shire’s Pipeline Compound SHP647

OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announces that on May 28,…

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Received Approval to Be Entered Into the Australian Register of Therapeutic Goods (ARTG) for use against COVID-19

PETALUMA, Calif.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized…